- Investor Relations Asia Pacific

WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

Please download the latest "Acrobat Reader" to view the PDF.

  • 2018-March-19
  • WuXi Biologics Reports Remarkable 2017 Annual Results Revenue Up 63.7% to a Record High of RMB1,618.8 Million Adjusted Net Profit Up 85.1% to RMB408.1 Million Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Increased Significantly (in PDF)
  • 2018-March-1
  • Press Release (Chinese Version) (in PDF)
  • 2018-February-8
  • Press Release (Chinese Version) (in PDF)
  • 2018-January-19
  • Press Release (Chinese Version) (in PDF)
  • 2018-January-9
  • WuXi Biologics Receives Best IPO Award and Best Investor Relations Award 2017 (in PDF)
  • 2017
  • 2017 Press Releases

  • Company's Index

  • About   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2018 Ltd. All rights reserved.
    DISCLAIMER: Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall Ltd. be liable for damages resulting from the use of the information provided on this website.